Lentiviral Vectors Market, By Product Type, By Therapeutic Area, By Manufacturing Scale, By Workflow Stage, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Lentiviral Vectors Market size was valued at US$ 170.10 Million in 2024, expanding at a CAGR of 11.92% from 2025 to 2032.

The Lentiviral Vectors Market involves the development and use of lentivirus-based delivery systems primarily for gene therapy, vaccine development, and research applications. Increasing demand for effective gene delivery methods in treating genetic disorders and cancers has expanded the use of lentiviral vectors, which are favored for their ability to integrate into host genomes and provide stable, long-term gene expression. In 2023, over 60% of gene therapy clinical trials incorporated lentiviral vectors to enhance therapeutic outcomes. However, challenges like high manufacturing costs, biosafety concerns, and potential insertional mutagenesis limit widespread adoption. Advances in vector engineering and scalable production methods offer promising opportunities to improve safety profiles and reduce costs. Additionally, growing investments in CAR-T cell therapies and immunotherapy research present significant avenues for market expansion as lentiviral vectors play a crucial role in modifying immune cells for targeted treatments.

Lentiviral Vectors Market- Market Dynamics

Advancements in gene delivery systems to accelerate lentiviral vector adoption

Advancements in gene delivery systems are accelerating the adoption of lentiviral vectors in therapeutic and research applications worldwide. The National Cancer Institute (NCI) reports that lentiviral vectors have become a cornerstone in CAR-T cell therapies, with several FDA-approved treatments utilizing these vectors to modify patients' immune cells for targeted cancer treatment. Additionally, the U.S. National Institutes of Health (NIH) has funded multiple programs aimed at improving lentiviral vector safety and scalability, addressing concerns related to insertional mutagenesis. In Europe, regulatory agencies such as the EMA have facilitated clinical trial approvals for lentiviral-based gene therapies, reflecting growing confidence in their potential. These efforts underscore the critical role of enhanced gene delivery technologies in expanding the reach of personalized medicine and advancing treatment options for genetic and acquired diseases.

Lentiviral Vectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.92% over the forecast period (2025-2032)

Based on product type segmentation, Lentiviral Packaging Systems was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Cancer was the leading Therapeutic Area in 2024

Based on Manufacturing Scale segmentation, Clinical Grade was the leading Manufacturing Scale in 2024

Based on Workflow Stage segmentation, Viral Packaging was the leading Workflow Stage in 2024

Based on Application segmentation, Cell Therapy (e.g., CAR-T) was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Lentiviral Vectors Market- Segmentation Analysis:

The Global Lentiviral Vectors Market is segmented on the basis of Product Type, Therapeutic Area, Manufacturing Scale, Workflow Stage, Application, and Region.

The market is divided into six categories based on product type: Lentiviral Packaging Systems, Lentiviral Plasmids, Custom Lentivirus Production Services, Ready-to-use Lentivirus, Lentiviral Promoter, and Lentiviral Fusion Tags. Lentiviral Packaging Systems dominate due to their role in vector assembly; Lentiviral Plasmids are essential for gene cloning; Custom Lentivirus Production Services offer tailored solutions; Ready-to-use Lentivirus provides convenience; Lentiviral Promoters and Fusion Tags support gene expression and protein tracking.

The market is divided into four categories based on Therapeutic Area: Cancer, Rare Diseases, Infectious Diseases, and Neurological Disorders. Cancer leads as the primary therapeutic area due to extensive CAR-T applications; Rare Diseases benefit from personalized gene therapies; Infectious Diseases see growing vector use for vaccine development; Neurological Disorders are emerging targets with increasing research in gene editing and vector delivery.

Lentiviral Vectors Market- Geographical Insights

The Lentiviral Vectors Market shows significant regional variation, with North America leading due to its well-established biopharmaceutical infrastructure, robust funding for gene therapy research, and supportive regulatory environment led by the FDA. The U.S. hosts numerous clinical trials utilizing lentiviral vectors, particularly in CAR-T cell therapies and rare genetic disorders. Europe is also a key player, with countries like Germany, the UK, and France investing heavily in gene therapy innovation and benefiting from the European Medicines Agency's streamlined regulatory pathways. The Asia-Pacific region is rapidly emerging, driven by increased government initiatives in China, Japan, and South Korea to advance biotechnology and cell therapy programs. Growing collaborations between academic institutions and biotech firms in these countries are accelerating clinical development and commercialization of lentiviral vector-based therapies. Meanwhile, Latin America and the Middle East are gradually expanding their capabilities through partnerships and infrastructure development, focusing on addressing regional genetic disorders and improving healthcare access.

Lentiviral Vectors Market- Competitive Landscape:

The competitive landscape of the Lentiviral Vectors Market is shaped by a combination of established biotechnology companies, emerging startups, and academic research institutions focused on advancing gene delivery technologies. Leading players are investing in the development of safer, more efficient lentiviral vector platforms to improve transduction efficiency and reduce insertional mutagenesis risks. Strategic collaborations and licensing agreements between biopharma companies and academic centers are common, enabling rapid innovation and clinical translation. Companies are also expanding manufacturing capabilities to meet growing demand for clinical-grade lentiviral vectors, emphasizing scalability and regulatory compliance. Additionally, competition is intensified by efforts to develop novel vector engineering techniques, such as self-inactivating vectors and targeted delivery systems, to enhance therapeutic efficacy. Intellectual property management and securing exclusive rights to proprietary technologies remain critical for maintaining market position and fostering long-term growth in this evolving sector.

Recent Developments:

In June 2024, Charles River Laboratories announced a strategic collaboration with the Gates Institute at University of Colorado Anschutz to manufacture lentiviral vectors, accelerating CAR-T cell therapy development for hematological cancers and enhancing advanced cell and gene therapy manufacturing capabilities.

In September 2024, Rentschler Biopharma launched lentiviral vector manufacturing services at its Stevenage, UK facility, introducing a new LVV toolbox to complement existing AAV vector offerings and accelerate advanced therapy development for gene and cell therapy applications, including rare diseases and cancer immunotherapy.

In April 2025, ViroCell Biologics manufactured a GMP lentiviral vector for UCL's clinical trial, accelerating innovative CAR T-cell therapy development for relapsed paediatric acute lymphoblastic leukaemia, with the first patient enrolled in March 2025, aiming to prevent relapse in childhood blood cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LENTIVIRAL VECTORS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aldevron
Bio-Techne
Cell and Gene Therapy Catapult
Charles River Laboratories
Creative Biogene
ExcellGene SA
GeneCopoeia
Merck KGaA
OriGene Technologies
Oxford Biomedica
Sartorius AG
SIRION Biotech
Thermo Fisher Scientific
VectorBuilder
Vigene Biosciences
Wuxi Advanced Therapies
Others

GLOBAL LENTIVIRAL VECTORS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Lentiviral Packaging Systems
Lentiviral Plasmids
Custom Lentivirus Production Services
Ready-to-use Lentivirus
Lentiviral Promoter
Lentiviral Fusion Tags

GLOBAL LENTIVIRAL VECTORS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Cancer
Rare Diseases
Infectious Diseases
Neurological Disorders

GLOBAL LENTIVIRAL VECTORS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

Research Grade
Clinical Grade
Commercial Grade

GLOBAL LENTIVIRAL VECTORS MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

Plasmid Construction
Viral Packaging
Purification & Concentration
QC & Analytics
Upstream Processing
Downstream Processing

GLOBAL LENTIVIRAL VECTORS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Gene Therapy
Cell Therapy (e.g., CAR-T)
Vaccine Development
Functional Genomics

GLOBAL LENTIVIRAL VECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5351

1. Lentiviral Vectors Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Lentiviral Vectors Market Snippet by Product Type
- 2.1.2. Lentiviral Vectors Market Snippet by Therapeutic Area
- 2.1.3. Lentiviral Vectors Market Snippet by Manufacturing Scale
- 2.1.4. Lentiviral Vectors Market Snippet by Workflow Stage
- 2.1.5. Lentiviral Vectors Market Snippet by Application
- 2.1.6. Lentiviral Vectors Market Snippet by Country
- 2.1.7. Lentiviral Vectors Market Snippet by Region
2.2. Competitive Insights

3. Lentiviral Vectors Key Market Trends

3.1. Lentiviral Vectors Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Lentiviral Vectors Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Lentiviral Vectors Market Opportunities
3.4. Lentiviral Vectors Market Future Trends

4. Lentiviral Vectors Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Lentiviral Vectors Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Lentiviral Vectors Market Landscape

6.1. Lentiviral Vectors Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Lentiviral Vectors Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Lentiviral Packaging Systems
- 7.1.3. Lentiviral Plasmids
- 7.1.4. Custom Lentivirus Production Services
- 7.1.5. Ready-to-use Lentivirus
- 7.1.6. Lentiviral Promoter
- 7.1.7. Lentiviral Fusion Tags

8. Lentiviral Vectors Market - By Therapeutic Area

8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
- 8.1.2. Cancer
- 8.1.3. Rare Diseases
- 8.1.4. Infectious Diseases
- 8.1.5. Neurological Disorders

9. Lentiviral Vectors Market - By Manufacturing Scale

9.1. Overview
- 9.1.1. Segment Share Analysis, By Manufacturing Scale, 2024 & 2032 (%)
- 9.1.2. Research Grade
- 9.1.3. Clinical Grade
- 9.1.4. Commercial Grade

10. Lentiviral Vectors Market - By Workflow Stage

10.1. Overview
- 10.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
- 10.1.2. Plasmid Construction
- 10.1.3. Viral Packaging
- 10.1.4. Purification & Concentration
- 10.1.5. QC & Analytics
- 10.1.6. Upstream Processing
- 10.1.7. Downstream Processing

11. Lentiviral Vectors Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 11.1.2. Gene Therapy
- 11.1.3. Cell Therapy (e.g., CAR-T)
- 11.1.4. Vaccine Development
- 11.1.5. Functional Genomics

12. Lentiviral Vectors Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Lentiviral Vectors Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Lentiviral Vectors Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Lentiviral Vectors Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Lentiviral Vectors Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Lentiviral Vectors Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Lentiviral Vectors Industry

13.1. Competitive Dashboard
- 13.1.1. Competitive Benchmarking
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. Aldevron
- 13.2.2. Bio-Techne
- 13.2.3. Cell and Gene Therapy Catapult
- 13.2.4. Charles River Laboratories
- 13.2.5. Creative Biogene
- 13.2.6. ExcellGene SA
- 13.2.7. GeneCopoeia
- 13.2.8. Merck KGaA
- 13.2.9. OriGene Technologies
- 13.2.10. Oxford Biomedica
- 13.2.11. Sartorius AG
- 13.2.12. SIRION Biotech
- 13.2.13. Thermo Fisher Scientific
- 13.2.14. VectorBuilder
- 13.2.15. Vigene Biosciences
- 13.2.16. Wuxi Advanced Therapies
- 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us